No profile data available.
Axim Biotechnologies, Inc. (AXIM) is a healthcare company in the chemical laboratory testing equipment industry, based in San Diego, United States, with about 6 full-time employees.
It reported revenue of $70,458 for fiscal year 2024, up 78.3% from fiscal year 2023, and net income of -$3.52 million. Its market capitalization was $1.05 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions.
Axim Biotechnologies reported $70,458 in revenue for fiscal year 2024, up 78.3% from $39,518 in fiscal year 2023.
$1.05 million as of October 9, 2026.
Listed companies of a similar size in the same industry (chemical laboratory testing equipment) include DarioHealth Corp. (DRIO), Intelligent Bio Solutions Inc. (INBS), Bluejay Diagnostics, Inc. (BJDX), GlucoTrack, Inc. (GCTK).